Startup Funding Recap: Sumary, Sparxity, Ancep and Redalpine Fund

Europe dominated the funding wires on November 10 and 11, 2026, with AI software, deeptech and new venture funds all making headlines. Here is the recap, grouped by stage and theme.

Seed and pre-seed rounds

Accounting and admin automation drew several early-stage checks.

• Sumary: $25M seed, led by Singular. The Danish AI accounting startup raised a pre-seed less than a year ago.
• Ancep: $8.5M, led by Creandum, with Kleiner Perkins and Vicus Ventures. It builds AI agents for commercial insurance brokers.
• Neobe Therapeutics: €6M seed, led by ARC Ventures. The London company engineers bacteria to help cancer drugs reach solid tumours.
• Agent F: $4M pre-seed. The Berlin startup builds AI agents for accounting and financial controlling.
• Numina: €1M pre-seed. The Copenhagen startup is building free accounting software for small businesses.
• Valkyrie Dynamics: €1M pre-seed, from venture studio Hexa. It makes miniature radars for drone interceptors.

Growth rounds and strategic capital

Larger checks went to infrastructure and deeptech.

• Sparxity: €80M cumulative funding after closing its Series A, led by ICM HPQC Fund. The Dresden company was formerly SpiNNcloud.
• PORT: €15M in equity and debt, led by EBRD and Balnord, for autonomous urban logistics.
• triPica: €12M from TiLT Capital Partners for billing software aimed at energy and telecom.
• Efferon: €4M from existing private investors in the DACH region, for sepsis treatment devices.
• Hedepy: €4M in venture debt from Orbit Capital for its online psychotherapy platform.

New funds

Investors are also stocking up.

• Redalpine: closed a $250M fund, RAC VIII, its biggest early-stage fund to date. It will invest mainly at seed and Series A.
• Noctua Science Ventures: €15M first close for a pre-seed fund focused on Austrian deeptech spin-offs.
• Proximal Ventures: $28M debut fund, led by former SignalFire investor Sahir Raoof, for AI in drug development.

The bigger picture

The biggest story is Anthropic, which set a price range of $70 to $78 per share and could raise up to $64B in its US IPO.

Below the headlines, the pattern is clear. AI agents for back-office work, especially accounting, attracted several rounds in a single day. Funds earmarked for science and deeptech are also growing, which suggests investors expect the next wave of European companies to come from labs and hardware, not just software. A giant IPO at the top and small pre-seed checks at the bottom may point to the same belief: AI is being funded at every stage, and the middle is where founders will need to show real revenue.